PTC Therapeutics, Inc. (NASDAQ:PTCT) is one of the most profitable biotech stocks to buy. On October 20, Bank of America ...

PTC Industries has received a Purchase Order from Gas Turbine Research Establishment (GTRE), Defence Research and Development ...

BofA raised the firm’s price target on PTC Therapeutics (PTCT) to $87 from $76 and keeps a Buy rating on the shares. The firm’s survey of 20 ...

PTC (NASDAQ: PTC) has outperformed the market over the past 10 years by 7.24% on an annualized basis producing an average annual return of 20.37%. Currently, PTC has a market capitalization of $24.39 ...

This was the stock's second consecutive day of losses.

PTC thermistors. Designed to increase board-level efficiency and lower costs in automotive and industrial applications, Vishay BCcomponents PTCES series devices combine maximum energy handling to 340J ...

Vishay’s PTCES series PTC thermistors deliver higher board-level efficiency and reduce component count in automotive and ...

PTC India Financial shares rallied on the back of a healthy set of numbers in the September quarter of financial year 2026 ...

Vishay Intertechnology, Inc. (NYSE: VSH) today introduced a new series of insulated, surface-mount inrush current limiting ...

Vishay has introduced a new series of insulated, surface-mount inrush current limiting positive temperature coefficient ...